Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2023 Filed May 22, 2023 19:48 UTC |
KAHN BARBARADirector
|
GiftCommon Stock | 3,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000137 · edgardoc.xml · nonDerivative · entry 3 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 19,648 F2 · shares: Shares were transferred from direct ownership to ownership under the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, upon vesting of previously awarded restricted stock units. F3 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:48 UTC |
KAHN BARBARADirector
|
GiftCommon Stock | 3,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000137 · edgardoc.xml · nonDerivative · entry 2 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,927 F2 · shares: Shares were transferred from direct ownership to ownership under the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:48 UTC |
KAHN BARBARADirector
|
GrantCommon Stock | 2,927 | $0.00 | $2.93 |
DisclosureSEC source: 0001093557-23-000137 · edgardoc.xml · nonDerivative · entry 1 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,903 F1 · shares: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:47 UTC |
Malady KyleDirector
|
GrantCommon Stock | 2,885 | $0.00 | $2.89 |
DisclosureSEC source: 0001093557-23-000136 · edgardoc.xml · nonDerivative · entry 1 Malady Kyle · CIK 0001760581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,529 F1 · shares: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Included in this number are 4,581 unvested restricted stock units, 2,885 of which were granted on May 18, 2023 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2024 Annual Meeting and 1,696 of which were granted on October 11, 2020 and shall vest through October 11, 2023. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:47 UTC |
TOPOL ERICDirector
|
GiftCommon Stock | 3,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000135 · edgardoc.xml · nonDerivative · entry 3 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Holdings Disclosed balance after: 375,016 F2 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F3 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:47 UTC |
TOPOL ERICDirector
|
GiftCommon Stock | 3,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000135 · edgardoc.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,911 F2 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:47 UTC |
TOPOL ERICDirector
|
GrantCommon Stock | 2,911 | $0.00 | $2.91 |
DisclosureSEC source: 0001093557-23-000135 · edgardoc.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,863 F1 · shares: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:45 UTC |
Dahut Karen MDirector
|
GiftCommon Stock | 3,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000134 · edgardoc.xml · nonDerivative · entry 5 Dahut Karen M · CIK 0001533450 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 10,716 F1 · shares: Shares were transferred from direct ownership to ownership under the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, with respect to which the reporting person is a trustee. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:45 UTC |
Dahut Karen MDirector
|
GiftCommon Stock | 3,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-23-000134 · edgardoc.xml · nonDerivative · entry 3 Dahut Karen M · CIK 0001533450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,450 F1 · shares: Shares were transferred from direct ownership to ownership under the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, upon vesting of previously awarded restricted stock units. F3 · balance_after: Included in this number are 4,450 unvested restricted stock units, 2,906 of which were granted on May 18, 2023 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2024 Annual Meeting and 1,544 of which were granted on August 11, 2020 and shall vest through August 11, 2023. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:45 UTC |
Dahut Karen MDirector
|
GrantCommon Stock | 2,906 | $0.00 | $2.91 |
DisclosureSEC source: 0001093557-23-000134 · edgardoc.xml · nonDerivative · entry 2 Dahut Karen M · CIK 0001533450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,398 F2 · shares: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 09, 2023 Filed May 9, 2023 22:24 UTC |
Stern SadieEVP Chief Human Resources Offi
|
SaleCommon Stock | 393 | $120.19 | $47,234.67 |
DisclosureSEC source: 0001093557-23-000122 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Offi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,859 F1 · shares: On December 14, 2022, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 66,505 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| April 27, 2023 Filed Apr 27, 2023 22:38 UTC |
Pacelli Steven RobertEVP Managing Director Dexcom V
|
SaleCommon Stock | 5,031 | $126.00 | $633,906.00 |
DisclosureSEC source: 0001093557-23-000120 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP Managing Director Dexcom V 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,686 F1 · shares: On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 20:36 UTC |
Pacelli Steven RobertEVP Managing Director Dexcom V
|
SaleCommon Stock | 412 | $124.68 | $51,368.16 |
DisclosureSEC source: 0001093557-23-000114 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP Managing Director Dexcom V 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,717 F1 · shares: On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 20, 2023 Filed Apr 20, 2023 22:39 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
SaleCommon Stock | 30,764 | $125.00 | $3,845,500.00 |
DisclosureSEC source: 0001093557-23-000110 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,613 F1 · shares: On December 5, 2022, Mr. Leach adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Leach. The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 64,633 unvested restricted stock units, 25,397 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 17,976 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 9,560 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 20, 2023 Filed Apr 20, 2023 22:39 UTC |
Regan Barry J.EVP Operations
|
SaleCommon Stock | 2,214 | $124.50 | $275,643.00 |
DisclosureSEC source: 0001093557-23-000109 · edgardoc.xml · nonDerivative · entry 1 Regan Barry J. · CIK 0001746313 · EVP Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,258 F1 · shares: On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan. The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| April 20, 2023 Filed Apr 20, 2023 22:39 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
SaleCommon Stock | 2,007 | $125.00 | $250,875.00 |
DisclosureSEC source: 0001093557-23-000108 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,505 F1 · shares: On November 29, 2022, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 17, 2023 Filed Apr 18, 2023 20:36 UTC |
Flynn Paul REVP Global Revenue
|
SaleCommon Stock | 2,781 | $120.00 | $333,720.00 |
DisclosureSEC source: 0001093557-23-000104 · edgardoc.xml · nonDerivative · entry 1 Flynn Paul R · CIK 0001850141 · EVP Global Revenue 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,112 F1 · shares: On September 9, 2022, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 52,112 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 10, 2023 Filed Apr 11, 2023 20:02 UTC |
Stern SadieEVP Chief Human Resources Offi
|
SaleCommon Stock | 393 | $112.35 | $44,153.55 |
DisclosureSEC source: 0001093557-23-000102 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Offi 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,252 F1 · shares: On December 14, 2022, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 66,505 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC |
SAYER KEVIN RDirector · President CEO and Chairman of
|
SaleCommon Stock | 3,599 | $115.70 | $416,390.98 |
DisclosureSEC source: 0001093557-23-000096 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President CEO and Chairman of 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,457 F1 · shares: On November 1, 2022, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F5 · price: This transaction was executed in multiple trades at prices ranging from $115.435 to $116.03. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC |
SAYER KEVIN RDirector · President CEO and Chairman of
|
SaleCommon Stock | 11,218 | $114.39 | $1,283,255.07 |
DisclosureSEC source: 0001093557-23-000096 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President CEO and Chairman of 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,056 F1 · shares: On November 1, 2022, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F4 · price: This transaction was executed in multiple trades at prices ranging from $114.065 to $115.02. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC |
SAYER KEVIN RDirector · President CEO and Chairman of
|
SaleCommon Stock | 5,995 | $113.83 | $682,422.84 |
DisclosureSEC source: 0001093557-23-000096 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President CEO and Chairman of 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,274 F1 · shares: On November 1, 2022, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $113.33 to $114.04. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC |
Brown Michael JonEVP Chief Legal Officer
|
SaleCommon Stock | 253 | $116.03 | $29,355.59 |
DisclosureSEC source: 0001093557-23-000095 · edgardoc.xml · nonDerivative · entry 3 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,870 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC |
Brown Michael JonEVP Chief Legal Officer
|
SaleCommon Stock | 950 | $115.08 | $109,329.52 |
DisclosureSEC source: 0001093557-23-000095 · edgardoc.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,123 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F4 · price: This transaction was executed in multiple trades at prices ranging from $114.70 to $115.45. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC |
Brown Michael JonEVP Chief Legal Officer
|
SaleCommon Stock | 2,409 | $114.07 | $274,804.99 |
DisclosureSEC source: 0001093557-23-000095 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,073 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $113.63 to $114.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 21:08 UTC |
Pacelli Steven RobertEVP Managing Director Dexcom V
|
SaleCommon Stock | 5,442 | $116.40 | $633,448.80 |
DisclosureSEC source: 0001093557-23-000091 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP Managing Director Dexcom V 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,129 F1 · shares: On September 15, 2022, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:14 UTC |
Dolan Matthew VincentSVP Corporate Strategy-Develop
|
SaleCommon Stock | 2,303 | $115.00 | $264,845.00 |
DisclosureSEC source: 0001093557-23-000089 · edgardoc.xml · nonDerivative · entry 1 Dolan Matthew Vincent · CIK 0001914994 · SVP Corporate Strategy-Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,569 F1 · shares: On December 15, 2021, Mr. Dolan adopted a 10b5-1 Plan which was amended on December 6, 2022. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Dolan. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 33,569 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 20:03 UTC |
Stern SadieEVP Chief Human Resources Offi
|
SaleCommon Stock | 393 | $111.86 | $43,960.98 |
DisclosureSEC source: 0001093557-23-000087 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,645 F1 · shares: On December 14, 2022, Ms. Stern adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 66,505 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:46 UTC |
Regan Barry J.EVP Operations
|
SaleCommon Stock | 2,010 | $106.27 | $213,602.70 |
DisclosureSEC source: 0001093557-23-000081 · edgardoc.xml · nonDerivative · entry 3 Regan Barry J. · CIK 0001746313 · EVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,472 F3 · shares: On November 1, 2022, Mr. Regan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:46 UTC |
Flynn Paul REVP Global Revenue
|
SaleCommon Stock | 2,782 | $106.27 | $295,643.14 |
DisclosureSEC source: 0001093557-23-000078 · edgardoc.xml · nonDerivative · entry 4 Flynn Paul R · CIK 0001850141 · EVP Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,893 F3 · shares: On September 9, 2022, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 52,112 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:46 UTC |
Dolan Matthew VincentSVP Corporate Strategy-Develop
|
SaleCommon Stock | 6,229 | $106.27 | $661,955.83 |
DisclosureSEC source: 0001093557-23-000077 · edgardoc.xml · nonDerivative · entry 5 Dolan Matthew Vincent · CIK 0001914994 · SVP Corporate Strategy-Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,872 F3 · shares: On December 15, 2021, Mr. Dolan adopted a 10b5-1 Plan which was amended on December 6, 2022. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Dolan. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 33,569 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Sylvain Jereme MEVP Chief Financial Officer
|
Disposition to issuerCommon Stock | 783 | $111.40 | $87,225.42 |
DisclosureSEC source: 0001093557-23-000085 · edgardoc.xml · nonDerivative · entry 4 Sylvain Jereme M · CIK 0001681267 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,111 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 54,661 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Sylvain Jereme MEVP Chief Financial Officer
|
Disposition to issuerCommon Stock | 1,857 | $111.40 | $206,867.94 |
DisclosureSEC source: 0001093557-23-000085 · edgardoc.xml · nonDerivative · entry 3 Sylvain Jereme M · CIK 0001681267 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,894 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 54,661 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Sylvain Jereme MEVP Chief Financial Officer
|
Disposition to issuerCommon Stock | 3,604 | $111.40 | $401,482.00 |
DisclosureSEC source: 0001093557-23-000085 · edgardoc.xml · nonDerivative · entry 2 Sylvain Jereme M · CIK 0001681267 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,751 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 54,661 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Sylvain Jereme MEVP Chief Financial Officer
|
Disposition to issuerCommon Stock | 3,374 | $111.40 | $375,860.23 |
DisclosureSEC source: 0001093557-23-000085 · edgardoc.xml · nonDerivative · entry 1 Sylvain Jereme M · CIK 0001681267 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,355 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 54,661 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Stern SadieEVP Chief Human Resources Offi
|
Disposition to issuerCommon Stock | 3,565 | $111.40 | $397,137.44 |
DisclosureSEC source: 0001093557-23-000084 · edgardoc.xml · nonDerivative · entry 2 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,038 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 66,505 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Stern SadieEVP Chief Human Resources Offi
|
Disposition to issuerCommon Stock | 2,550 | $111.40 | $284,067.45 |
DisclosureSEC source: 0001093557-23-000084 · edgardoc.xml · nonDerivative · entry 1 Stern Sadie · CIK 0001797971 · EVP Chief Human Resources Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,603 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 66,505 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
Disposition to issuerCommon Stock | 2,646 | $111.40 | $294,761.75 |
DisclosureSEC source: 0001093557-23-000083 · edgardoc.xml · nonDerivative · entry 3 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,512 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
Disposition to issuerCommon Stock | 1,737 | $111.40 | $193,500.06 |
DisclosureSEC source: 0001093557-23-000083 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,158 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC |
Selvaraj Shelly RamasamySVP Chief Information Officer
|
Disposition to issuerCommon Stock | 2,089 | $111.40 | $232,712.51 |
DisclosureSEC source: 0001093557-23-000083 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,895 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:47 UTC |
SAYER KEVIN RDirector · President CEO and Chairman of
|
Disposition to issuerCommon Stock | 11,047 | $111.40 | $1,230,624.75 |
DisclosureSEC source: 0001093557-23-000082 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President CEO and Chairman of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,269 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:47 UTC |
SAYER KEVIN RDirector · President CEO and Chairman of
|
Disposition to issuerCommon Stock | 9,141 | $111.40 | $1,018,298.26 |
DisclosureSEC source: 0001093557-23-000082 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President CEO and Chairman of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,316 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:47 UTC |
SAYER KEVIN RDirector · President CEO and Chairman of
|
Disposition to issuerCommon Stock | 17,302 | $111.40 | $1,927,425.50 |
DisclosureSEC source: 0001093557-23-000082 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President CEO and Chairman of 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,457 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 115,682 unvested restricted stock units, 54,422 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 43,336 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 17,924 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC |
Regan Barry J.EVP Operations
|
Disposition to issuerCommon Stock | 3,274 | $111.40 | $364,720.33 |
DisclosureSEC source: 0001093557-23-000081 · edgardoc.xml · nonDerivative · entry 2 Regan Barry J. · CIK 0001746313 · EVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,482 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC |
Regan Barry J.EVP Operations
|
Disposition to issuerCommon Stock | 2,406 | $111.40 | $268,025.99 |
DisclosureSEC source: 0001093557-23-000081 · edgardoc.xml · nonDerivative · entry 1 Regan Barry J. · CIK 0001746313 · EVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,756 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 62,232 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 6,684 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,416 of which were granted on November 19, 2020 and shall vest through November 19, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC |
Pacelli Steven RobertEVP Managing Director Dexcom V
|
Disposition to issuerCommon Stock | 2,405 | $111.40 | $267,914.60 |
DisclosureSEC source: 0001093557-23-000080 · edgardoc.xml · nonDerivative · entry 3 Pacelli Steven Robert · CIK 0001359098 · EVP Managing Director Dexcom V 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,571 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC |
Pacelli Steven RobertEVP Managing Director Dexcom V
|
Disposition to issuerCommon Stock | 5,990 | $111.40 | $667,280.01 |
DisclosureSEC source: 0001093557-23-000080 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP Managing Director Dexcom V 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,976 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC |
Pacelli Steven RobertEVP Managing Director Dexcom V
|
Disposition to issuerCommon Stock | 3,274 | $111.40 | $364,720.33 |
DisclosureSEC source: 0001093557-23-000080 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP Managing Director Dexcom V 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,966 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 39,132 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 13,288 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC |
Flynn Paul REVP Global Revenue
|
Disposition to issuerCommon Stock | 5,643 | $111.40 | $628,624.56 |
DisclosureSEC source: 0001093557-23-000078 · edgardoc.xml · nonDerivative · entry 3 Flynn Paul R · CIK 0001850141 · EVP Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,675 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 52,112 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC |
Flynn Paul REVP Global Revenue
|
Disposition to issuerCommon Stock | 5,724 | $111.40 | $637,647.88 |
DisclosureSEC source: 0001093557-23-000078 · edgardoc.xml · nonDerivative · entry 2 Flynn Paul R · CIK 0001850141 · EVP Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,318 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 52,112 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC |
Flynn Paul REVP Global Revenue
|
Disposition to issuerCommon Stock | 5,478 | $111.40 | $610,243.72 |
DisclosureSEC source: 0001093557-23-000078 · edgardoc.xml · nonDerivative · entry 1 Flynn Paul R · CIK 0001850141 · EVP Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,042 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 52,112 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 11,700 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,512 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.